$5.5B J&J talc deal could end decade-long legal battle



Johnson & Johnson reached a potential $5.5 billion settlement on Monday in an effort to settle past legal woes over claims that its talc products were behind cases of ovarian cancer. The settlement would cover roughly 76,000 claims with no cap on payouts.
Reported by 4 outlets — The Hill, CNBC Top News, Seattle Times, New York Post. See all sources ↓
Johnson & Johnson reached a potential $5.5 billion settlement on Monday in an effort to settle past legal woes over claims that its talc products were behind cases of ovarian cancer. The settlement would cover roughly 76,000 claims with no cap on payouts. Johnson & Johnson said it plans to issue the first round of...
Read the full report at The Hill ↗
Why it matters
4 outlets are covering this politics story — one to watch as reporting develops.
- What's the story?
- Johnson & Johnson reached a potential $5.5 billion settlement on Monday in an effort to settle past legal woes over claims that its talc products were behind cases of ovarian cancer. The settlement would cover roughly 76,000 claims with no cap on payouts.
- How widely is it covered?
- 4 outlets, average source rating 6.3/10.
- When was it last updated?
- 1d ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card4 outlets1CoverageScouting report
Johnson & Johnson says it will pay out $5.5B in sweeping talc deal that could end decade-long legal battle
Sources4TypeCoverageThe Hill
CNBC Top News
Seattle Times
New York Post